[1. Bear HD. Indication for neoadjuvant chemotherapy for breast cancer. Semin Oncol. 1998; 25(2 Suppl3):3-12.]Search in Google Scholar
[2. Botti C,Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Prognotic value of lymph node metastasis after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am CollSurg. 1995; 181 (3):202-208.]Search in Google Scholar
[3. Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. AmJ Surg. 1998;76:502-506.10.1016/S0002-9610(98)00253-0]Search in Google Scholar
[4. Kuerer HM, Newman LA, Fomage BD, Dhingra K, Hunt KK, Buzdar AU, et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 1998;5(3):673-80.10.1007/BF02303476]Search in Google Scholar
[5. Machiavelli MR, Romero AO, Perez JE, Lacava JA, Dominguez ME, Rodriguez R, et al. Prognostic significance of pathological response of primary tumour and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am. 1998 ;4(2):125-31.]Search in Google Scholar
[6. Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathological assessment of response to induction chemotherapy in breast cancer.CancerRes. 1986;46(5):2578-81.]Search in Google Scholar
[7. Gazet J-C,Coombes RC, Ford HT, Griffin M, Coibishley C, Makinde V, et al. Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. Br J Cancer. 1996; 73(6): 758-762.10.1038/bjc.1996.132]Search in Google Scholar
[8. Kennedy SM, Merino MJ, Swain S, Lippman ME. The effect of hormonal and chemotherapy on tumoral and non-neoplastic breast tissue. Hum Pathol. 1990;21(2): 192 -8.10.1016/0046-8177(90)90128-R]Search in Google Scholar
[9. Khanna AK, Saxena SK, Khan a S, Kumar A. Histopathological changes following anterior chemotherapy in advanced breast cancer. Ind J Cancer. 1990;27(2):109-15.]Search in Google Scholar
[10. Khanna AK, Saxena SK, Khan a S, and Mistra MK:Tumor response to chemotherapy as a primary treatment in advanced breast cancer. Ind J Slug. 1991;53(6):239-45.]Search in Google Scholar
[11. Mortimer JE, Taylor ME. Can chemotherapy alter the histologic features of breast cancer. Am J Clin PathoL 1994; 102(2): 147-9.10.1093/ajcp/102.2.147]Search in Google Scholar
[12. Moll UM, Chumas J. Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract. 1997; 193(3): 187-96.10.1016/S0344-0338(97)80076-3]Search in Google Scholar
[13. Hayward JL, Carbone PP, Heusen JC, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in advanced breast cancer. Br J Cancer. 1977;35:292-8.10.1038/bjc.1977.422025288856236]Search in Google Scholar
[14. WHO Handbook for Reporting Results of Cancer Treatment WHO Offset publication No. 48. Geneva: World Health Organization; 1979.]Search in Google Scholar
[15. Sinn HP, Schmod H, Junkermann H, Huober J, Leppien G, Kaufmann M, et al. Histologische regression des ma mmac arzino mas nach primarer (neoadjuvanter) chemotherapie. Geburtsh Frauenheilk. 1994;54(10):552-8.10.1055/s-2007-10223388001751]Search in Google Scholar
[16. Gampenrieder SP, Rinnerthaler G, Greil R. Neoadjuvant chemotherapy and targeted therapy in breast cancer past, present, and future. J Oncol. 2013;2013:732047.10.1155/2013/732047376220924027583]Search in Google Scholar
[17. Honkoop AH, Pinedo HM, De Jong de JS, Verheul HM, Linn SC, Hoekman K, et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol. 1997; 107(2):211-8.10.1093/ajcp/107.2.2119024070]Search in Google Scholar
[18. Sharkey FE, Addington SL, Flowerl J, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol. 1996;9(9):893-900.]Search in Google Scholar
[19. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230(l):72-78.10.1097/00000658-199907000-00011]Search in Google Scholar
[20. Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, et al. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol. 1999;6(8):762-7.10.1007/s10434-999-0762-4]Search in Google Scholar
[21. Paradinas FJ. Primary and secondary breast disorders. In: StansfeldAG, d'Ardene AJ, editors. Lymph node biopsy interpretation. 2nd ed. Edinburgh: Churchill Livingstone; 1992. p. 171-86.]Search in Google Scholar
[22. Sahoo S, Lester SC. Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med. 2009; 133(4):633-42.10.5858/133.4.633]Search in Google Scholar
[23. Pinder SE, Ptovenzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50(4):409-17.10.1111/j.1365-2559.2006.02419.x]Search in Google Scholar
[24. Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol. 1979;11:1-466.]Search in Google Scholar
[25. Misdorp W, Hart G, Delemarre JFM, Voute PA, van der Eijken JW. An analysis of spontaneous and chemotherapy-associated changes in skeletal osteosarcomas. J Pathol. 1988; 156(2): 119-28.10.1002/path.1711560206]Search in Google Scholar
[26. Rosen G, Capparos B, Huvos AG, Kosloff C, Nirenbetg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma:selection of postoperative chemotherapy based on response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49(6): 1221-30. 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E]Search in Google Scholar